- Recce Pharmaceuticals (RCE) Board of Directors has unanimously appointed James Graham as the company’s new CEO
- James has served as Recce’s Executive Director of Marketing and Business Development for the last five years
- In addition to his new duties as CEO, James will continue to serve as a Director on the Board
- His appointment takes effect on August 28, and comes with an annual salary of $300,000
- James will oversee the company as it approaches a number of critical milestones, including a clinical trial and COVID-19 studies
- Recce Pharmaceuticals closed 0.37 per cent in the red for $1.36 each
